within Pharmacolibrary.Drugs.ATC.N;

model N06BA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.75,
    Cl             = 2.166666666666667e-06,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00544,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0061333333333333335,
    Tlag           = 1800
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N06BA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dexamfetamine (also known as dextroamphetamine) is a central nervous system stimulant of the phenethylamine class. It is used for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy, and is approved for these indications in numerous countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects (both sexes) after a single oral dose.</p><h4>References</h4><ol><li><p>Blick, SK, &amp; Keating, GM (2007). Lisdexamfetamine. <i>Paediatric drugs</i> 9(2) 129–138. DOI:<a href=\"https://doi.org/10.2165/00148581-200709020-00007\">10.2165/00148581-200709020-00007</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17407369/\">https://pubmed.ncbi.nlm.nih.gov/17407369</a></p></li><li><p>Kämmerer, W (2024). Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine-A literature review. <i>Human psychopharmacology</i> 39(6) e2910–None. DOI:<a href=\"https://doi.org/10.1002/hup.2910\">10.1002/hup.2910</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39024047/\">https://pubmed.ncbi.nlm.nih.gov/39024047</a></p></li><li><p>Comiran, E, et al., &amp; Limberger, RP (2021). Lisdexamfetamine and amphetamine pharmacokinetics in oral fluid, plasma, and urine after controlled oral administration of lisdexamfetamine. <i>Biopharmaceutics &amp; drug disposition</i> 42(1) 3–11. DOI:<a href=\"https://doi.org/10.1002/bdd.2254\">10.1002/bdd.2254</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33119133/\">https://pubmed.ncbi.nlm.nih.gov/33119133</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N06BA02;
